These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 23873104)
1. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer. Zhang H; Wen X; Lu X; Zhang H Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the association between NQO1 Pro187Ser polymorphism and colorectal cancer in Asians. Zhao H; Zhu F; Sun J; Meng X Tumour Biol; 2014 Mar; 35(3):2111-6. PubMed ID: 24142528 [TBL] [Abstract][Full Text] [Related]
3. Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis. Chen J; Lin Y; Zhang R; Huang ZJ; Pan XG Arch Med Res; 2012 Jan; 43(1):58-66. PubMed ID: 22306249 [TBL] [Abstract][Full Text] [Related]
4. Association of NAD (P) H Quinine Oxidoreductase 1 rs1800566 Polymorphism with Bladder and Prostate Cancers - a Systematic Review and Meta-Analysis. Abedinzadeh M; Moghimi M; Dastgheib SA; Maleki H; Salehi E; Zare M; Jarahzadeh HM; Neamatzadeh H Klin Onkol; 2020; 33(2):92-100. PubMed ID: 32303129 [TBL] [Abstract][Full Text] [Related]
5. The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 subjects. Guo ZJ; Feng CL Asian Pac J Cancer Prev; 2012; 13(12):6343-8. PubMed ID: 23464456 [TBL] [Abstract][Full Text] [Related]
6. NAD(P)H: quinone oxidoreductase 1 gene rs1800566 polymorphism increases the risk of cervical cancer in a Chinese Han sample: A STROBE-complaint case-control study. Yang S; Zhao J; Li L Medicine (Baltimore); 2020 May; 99(20):e19941. PubMed ID: 32443295 [TBL] [Abstract][Full Text] [Related]
7. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis. Ding R; Lin S; Chen D Int J Colorectal Dis; 2012 Jul; 27(7):885-92. PubMed ID: 22215148 [TBL] [Abstract][Full Text] [Related]
8. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis. Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S Diagn Pathol; 2014 May; 9():100. PubMed ID: 24884893 [TBL] [Abstract][Full Text] [Related]
9. The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analysis of 15 studies. Yang S; Jin T; Su HX; Zhu JH; Wang DW; Zhu SJ; Li S; He J; Chen YH PLoS One; 2015; 10(1):e0116500. PubMed ID: 25602258 [TBL] [Abstract][Full Text] [Related]
10. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis. Gong M; Yi Q; Wang W Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485 [TBL] [Abstract][Full Text] [Related]
11. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380 [TBL] [Abstract][Full Text] [Related]
12. Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis. Liu K; Tian H; Yu KZ; Shen WY; Mao ZC; Jin CH; Pan HB; He JX Tumour Biol; 2014 Mar; 35(3):2063-8. PubMed ID: 24213850 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer. Freriksen JJ; Salomon J; Roelofs HM; Te Morsche RH; van der Stappen JW; Dura P; Witteman BJ; Lacko M; Peters WH J Hum Genet; 2014 Jul; 59(7):381-6. PubMed ID: 24830960 [TBL] [Abstract][Full Text] [Related]
14. Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses. Wang XC; Wang J; Tao HH; Zhang C; Xu LF Int J Occup Med Environ Health; 2017 Jul; 30(5):791-802. PubMed ID: 28589969 [TBL] [Abstract][Full Text] [Related]
15. A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis. Yu H; Liu H; Wang LE; Wei Q PLoS One; 2012; 7(1):e30566. PubMed ID: 22272361 [TBL] [Abstract][Full Text] [Related]
16. NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population. Yin J; Wang L; Wang X; Zheng L; Shi Y; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H Scand J Gastroenterol; 2014 Mar; 49(3):317-22. PubMed ID: 24354914 [TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt. Goerlitz D; Amr S; Dash C; Saleh DA; El Daly M; Abdel-Hamid M; El Kafrawy S; Hifnawy T; Ezzat S; Abdel-Aziz MA; Khaled H; Zheng YL; Mikhail N; Loffredo CA Urol Oncol; 2014 Jan; 32(1):47.e15-20. PubMed ID: 24035474 [TBL] [Abstract][Full Text] [Related]
18. Genetic association of the NQO1 rs1800566 (609C>T) variant with risk of preeclampsia in the Chinese Han population. Zhao L; Liu J; Tan P; Zhang W; Gao Q; Li X; Lin Y; Dong Q; Wang H; Liu S Pregnancy Hypertens; 2017 Oct; 10():42-45. PubMed ID: 29153688 [TBL] [Abstract][Full Text] [Related]
19. Association between NQO1 C609T polymorphism and colorectal cancer risk. Wang Y; Zhang G; Luo Y Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397 [TBL] [Abstract][Full Text] [Related]
20. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population. Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]